↓ Skip to main content

Dove Medical Press

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?

Overview of attention for article published in Neuropsychiatric Disease and Treatment, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
facebook
1 Facebook page
googleplus
1 Google+ user
video
1 YouTube creator

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
19 Mendeley
Title
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing–remitting multiple sclerosis?
Published in
Neuropsychiatric Disease and Treatment, October 2012
DOI 10.2147/ndt.s36771
Pubmed ID
Authors

Zsolt Mezei, Daniel Bereczki, Lilla Racz, Laszlo Csiba, Tünde Csepany

Abstract

Decreased relapse rate and slower disease progression have been reported with long-term use of immunomodulatory treatments (IMTs, interferon beta or glatiramer acetate) in relapsing-remitting multiple sclerosis. There are, however, patients who do not respond to such treatments, and they can be potential candidates for alternative therapeutic approaches.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 26%
Other 3 16%
Student > Master 2 11%
Professor 2 11%
Researcher 2 11%
Other 2 11%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 7 37%
Psychology 2 11%
Nursing and Health Professions 1 5%
Agricultural and Biological Sciences 1 5%
Neuroscience 1 5%
Other 1 5%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2012.
All research outputs
#3,407,369
of 25,371,288 outputs
Outputs from Neuropsychiatric Disease and Treatment
#491
of 3,132 outputs
Outputs of similar age
#24,247
of 190,982 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#3
of 17 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,982 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.